Journal article
Rheumatoid arthritis patients receive less frequent acute reperfusion and secondary prevention therapy after myocardial infarction compared with the general population
S Van Doornum, C Brand, V Sundararajan, AE Ajani, IP Wicks
Arthritis Research and Therapy | Published : 2010
DOI: 10.1186/ar3151
Abstract
Introduction: The 30-day case-fatality rate after acute myocardial infarction (MI) for rheumatoid arthritis (RA) patients is twice that of the general population. This study compared the frequency and timeliness of early reperfusion therapy and treatment with secondary prevention medications after acute MI in RA patients and controls.Methods: We performed a structured medical chart review of RA patients and matched controls who had been admitted with acute MI to one of three hospitals in Victoria, Australia, between 1995 and 2005. The administration and timing of acute reperfusion therapy and in-hospital treatment with secondary prevention medications were compared between the two groups. Ac..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
We gratefully acknowledge the assistance of Ms Angela Wood in the chart abstraction and Ms Alexandra Gorelik for statistical advice. This research was supported by an Arthritis Australia Grant-in-aid (Win Dunne Grant) and The Walkom Trust. The funding bodies had no role in the study design, completion, or writing of the manuscript. IPW is supported by a Clinical Practitioner Fellowship (461203) from the National Health and Medical Research Council of Australia.